These results, together with a previous report displaying that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the idea of targeting ACKR3 as a novel solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-similar Problems. In reaction to this problem, https://patrickv739ofu4.blogdiloz.com/profile